DFTX

#1886
Definium Therapeutics, Inc. Common Shares
22.16 USD
-0.40%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
22.08
22.38
Rango anual
14.62
22.72
Cambio diario
-0.40%
Variación mensual
+21.09%
Variación en los últimos 6 meses
+46.66%
Cambio anual
+46.66%
Cierres anteriores
22.25
Abrir
22.38
Bid
Ask
Mínimo
22.08
High
22.38
Volumen
304
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 2.21 B
  • Employee 106
  • Founded 2010
  • CEO Robert Barrow
  • Website www.definiumtx.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00F13HYQ7
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Definium Therapeutics Inc

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.